<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Antimicrob Resist Infect Control</journal-id><journal-id journal-id-type="iso-abbrev">Antimicrob Resist Infect Control</journal-id><journal-title-group><journal-title>Antimicrobial Resistance and Infection Control</journal-title></journal-title-group><issn pub-type="epub">2047-2994</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4474617</article-id><article-id pub-id-type="publisher-id">2047-2994-4-S1-P80</article-id><article-id pub-id-type="doi">10.1186/2047-2994-4-S1-P80</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Compliance with antibiotic prophylaxis guidelines in a university hospital&#x02019;s neurosurgical unit: a 7-year follow-up</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Agostinho</surname><given-names>A</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Olearo</surname><given-names>F</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Delannoy</surname><given-names>D</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Fouchard-Chavatte</surname><given-names>F</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Goascoz</surname><given-names>M-C</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Ares</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Cabrilo</surname><given-names>I</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Gautschi</surname><given-names>O</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A9"><name><surname>Tessitore</surname><given-names>E</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A10"><name><surname>Bijlenga</surname><given-names>P</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A11"><name><surname>Czarnetzki</surname><given-names>C</given-names></name><xref ref-type="aff" rid="I5">5</xref></contrib><contrib contrib-type="author" id="A12"><name><surname>Lysakowski</surname><given-names>C</given-names></name><xref ref-type="aff" rid="I5">5</xref></contrib><contrib contrib-type="author" id="A13"><name><surname>Schaller</surname><given-names>K</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A14"><name><surname>Harbarth</surname><given-names>S</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Infection Control Program, H&#x000f4;pitaux Universitaires de Gen&#x000e8;ve (HUG), Gen&#x000e8;ve 14, Switzerland</aff><aff id="I2"><label>2</label>Neurosciences Department, H&#x000f4;pitaux Universitaires de Gen&#x000e8;ve (HUG), Gen&#x000e8;ve 14, Switzerland</aff><aff id="I3"><label>3</label>Operating Room Management, H&#x000f4;pitaux Universitaires de Gen&#x000e8;ve (HUG), Gen&#x000e8;ve 14, Switzerland</aff><aff id="I4"><label>4</label>Internal Control &#x00026; Audit Service, H&#x000f4;pitaux Universitaires de Gen&#x000e8;ve (HUG), Gen&#x000e8;ve 14, Switzerland</aff><aff id="I5"><label>5</label>Anesthesiology Department, H&#x000f4;pitaux Universitaires de Gen&#x000e8;ve (HUG), Gen&#x000e8;ve 14, Switzerland</aff><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>16</day><month>6</month><year>2015</year></pub-date><volume>4</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Antimicrobial Resistance and Infection Control: Abstracts from the 3rd International Conference on Prevention and Infection Control (ICPIC 2015)</named-content><named-content content-type="supplement-editor">Didier Pittet, Stephen Harbarth and Andreas Voss</named-content><named-content content-type="supplement-sponsor">Publication of this supplement has been funded by the International Consortium for Prevention and Infection Control (ICPIC). The Supplement Editors declare that they have no competing interests.</named-content></supplement><fpage>P80</fpage><lpage>P80</lpage><permissions><copyright-statement>Copyright &#x000a9; 2015 Agostinho et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Agostinho et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.aricjournal.com/content/4/S1/P80"/><conference><conf-date>16-19 June 2015</conf-date><conf-name>3rd International Conference on Prevention and Infection Control (ICPIC 2015)</conf-name><conf-loc>Geneva, Switzerland</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Surgical site infections (SSIs) are costly complications in neurosurgical practice and can be prevented by adequate perioperative antibiotic administration. Antibiotic prophylaxis (ABP) guidelines for neurosurgical procedures have been in place for 10 years at the HUG nevertheless the long-term compliance with these guidelines has not been evaluated.</p></sec><sec><title>Objectives</title><p>To assess the appropriate use and guideline-compliance of ABP in neurosurgery in 2007 versus 2014.</p></sec><sec sec-type="methods"><title>Methods</title><p>We performed 2 surveys on the adequacy of ABP including surveillance data on spinal and cranial surgeries collected during a 4-month period in 2007 compared with a 2<sup>nd</sup> period (1.10.13 to 30.09.11) addressing spinal surgeries only. Adequate ABP was defined as correct choice and dosage of the AB (considering also MRSA carriers), optimal timing of the administration (&#x0003c; 1h before surgical incision) and a second dose administration of intraoperative ABP if the operation lasts &#x0003e; 4 hours.</p></sec><sec sec-type="results"><title>Results</title><p>In the survey of 2007, 177 operations were included compared to 314 operations in 2014. Overall, we noticed improvement in guideline compliance over the last 7 years. In 2007 ABP was omitted in 16% (28/177) of the interventions compared to 2% (7/314) in 2014. The choice and dose of the AB remained adequate over the years (98% (146/149) of the operations in 2007 versus 99% (304/307) in 2014). Improvement in the timing was also noted, passing from 52% (77/149) of the procedures with the ABP administration within the 1<sup>st</sup> hour, to 81% (248/307) during the 2<sup>nd</sup> period. In 2007, ABP was administrated too early (&#x0003e; 1 hour before the incision) in many cases. In 2014, more patients (39%, 7/18 vs 12%, 2/17) did not receive the repeated dose of ABP when required.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>We report an improvement of the compliance with ABP guidelines in neurosurgery in particularly regarding antibiotic timing and coverage. More efforts are needed to further optimize ABP in high-risk patients and procedures.</p></sec><sec><title>Disclosure of interest</title><p>None declared.</p></sec></body></article>